Pharmig India 2026

Pharmig India 2026 is the annual global congress for pharmaceutical microbiology, contamination control and sterility assurance, bringing together the professionals responsible for maintaining microbiological quality across modern pharmaceutical manufacturing. Taking place on 3–4 December 2026 in Hyderabad, the congress is designed for microbiologists, QA/QC leaders, sterility assurance professionals, manufacturing and plant leaders, validation and compliance experts, and other specialists responsible for contamination-control decisions.

The 2026 edition builds on the momentum of Pharmig India’s previous editions and the growing need for practical, evidence-based approaches to contamination control. With EU GMP Annex 1, Contamination Control Strategies, environmental monitoring, aseptic processing and inspection expectations continuing to shape sterile manufacturing, the congress focuses on the questions practitioners face inside their facilities rather than simply revisiting regulatory theory.

Pharmig India 2026 is built around practical industry learning, bringing experienced practitioners together to examine real contamination-control challenges, investigation approaches, microbiological risks and the decisions that determine whether a pharmaceutical quality system can withstand regulatory scrutiny. The emphasis is on experience, evidence and implementation, creating a forum where professionals can discuss what actually works in manufacturing environments.